Accepted at 3:16 a.m. May, 07, 2026 by braviboron
Author: braviboron
Related Note: 1745198805265
Rationale for change

Reformat

Text Text
Extra
Extra (Synced)
Empty field
Personal Notes
Empty field
Missed Questions
Empty field
eTG Complete
Talley & O'Connor
Empty field
Additional Resources
Additional Resources (Synced)
Empty field
Source
One by one
Empty field
#Malleus_CM::#Guidelines::New_Zealand::RANZCOG_(Royal_Australian_and_New_Zealand_College_of_Obstetricians_and_Gynaecologists)::Prophylactic_antibiotics_in_obstetrics_and_gynaecology #Malleus_CM::#Subjects::Obstetrics_&_Gynaecology::01_Obstetrics::01_Pregnancy::02_Mother::Premature_Rupture_of_Membranes::10_Management #Malleus_CM::#Resources_by_Rotation::Obstetrics_&_Gynaecology #Malleus_CM::#Pharmacology::06_Anti-infectives::01_Antibacterials::07_Penicillins::Amoxicillin::03_Indications #Malleus_CM::#Guidelines::Australia::National::RANZCOG_(Royal_Australian_and_New_Zealand_College_of_Obstetricians_and_Gynaecologists)::Prophylactic_antibiotics_in_obstetrics_and_gynaecology #Malleus_CM::#eTG_Complete::Antibiotic::Perinatal_infections::Prophylaxis_for_preterm_prelabour_rupture_of_membranes #Malleus_CM::#Pharmacology::06_Anti-infectives::01_Antibacterials::06_Macrolides::Erythromycin::03_Indications #Malleus_CM::#Pharmacology::06_Anti-infectives::01_Antibacterials::07_Penicillins::Ampicillin::03_Indications